Skip to main content
Log in

Evaluierung und Management der Enuresis

Ein Update

Evaluation und management of enuresis

An update

  • CME Weiterbildung · Zertifizierte Fortbildung
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Enuresis ist als Einnässen im Schlaf in mindestens 2 Nächten im Monat nach dem 5. Lebensjahr definiert. In diesem Alter nässen 15 bis 20% aller Kinder noch ein. Mehr als die Hälfte dieser Kinder zeigt zusätzlich tagsüber Pollakisurie, Drangsymptome und Harninkontinenz (nicht monosymptomatische Enuresis). Der andere Teil der Kinder ist tagsüber unauffällig und nässt nur nachts ein (monosymptomatische Enuresis). Nächtliche Polyurie, Detrusorüberaktivität sowie eine verminderte Erweckbarkeit sind pathogenetisch die Hauptursachen. Psychologisch-psychiatrische Aspekte, genetische Faktoren und Obstipation spielen ätiologisch eine zusätzliche Rolle. Jeder Therapie muss obligat eine Basisdiagnostik vorausgehen. Anamnese, körperliche Untersuchung, Ultraschall des Harntrakts, Harnuntersuchung und Miktionsprotokoll sind Voraussetzung für einen erfolgversprechenden Therapieansatz. Die Eckpfeiler der primären Enuresistherapie sind allgemeine Verhaltensmaßregeln, Pharmakotherapie und Alarmgeräte. Therapieresistente enuretische Kinder bedürfen einer neuerlichen erweiterten Evaluation und meist einer multidisziplinären Therapie. Bei sorgfältiger Evaluierung und kausaler Therapie sind heute mit dem breiten therapeutischen Spektrum Erfolgsraten um 80% zu erzielen.

Abstract

Enuresis is defined as nocturnal bed wetting for at least 2 nights per month in children older than 5 years. At this age the prevalence of enuresis is about 15–20%. More than 50% of these children show day time symptoms, such as frequency, urgency and incontinence (non-monosymptomatic enuresis). The other children are asymptomatic during day time and wet the bed during the night time (monosymptomatic enuresis). The main pathogenetic factors are nycturia, detrusor overactivity and reduced arousability. Psychological and psychiatric aspects, genetics and obstipation play an additional role in the etiology. Basic diagnostic investigations are mandatory before treatment. Clinical history, physical examination, sonography of the urinary tract, urinalysis and bladder diary are prerequisites before any therapeutic steps are taken. The cornerstones of primary enuresis therapy are general lifestyle advice, pharmacotherapy and alarm devices. Therapy-resistant children deserve further evaluation and a multidisciplinary therapy approach. After careful evaluation specific therapy is efficient in approximately 80% of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Austin PF, Ferguson G, Yan Y et al (2008) Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial. Pediatrics 122:1027–1032

    Article  PubMed  Google Scholar 

  2. Baeyens D, Roeyers H, Hoebeke P et al (2004) Attention deficit/hyperactitiy disorder in children with nocturnal enuresis. J Urol 171:2576–2579

    Article  PubMed  Google Scholar 

  3. Björkström G, Hellström AL, Andersson S (2000) Electro-acupuncture in the treatment of children with monosymptomatic nocturnal enuresis. Scand J Urol Nephrol 34:21–26

    Article  PubMed  Google Scholar 

  4. Bradbury MG, Meadow SR (1995) Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Paediatr 84:1014–1018

    Article  CAS  PubMed  Google Scholar 

  5. Butler RJ, Holland P, Gasson S et al (2007) Exploring potential mechanisms in alarm treatment for primary nocturnal enuresis. Scand J Urol Nephrol 41:407–413

    Article  PubMed  Google Scholar 

  6. Gepertz S, Nevéus T (2004) Imipramine for therapy resistant enuresis: a retrospective evaluation. J Urol 171:2607–2610

    Article  CAS  PubMed  Google Scholar 

  7. Glazener CM, Evans JH (2000) Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev; CD002117

  8. Glazener CM, Evans JH (2002) Desmopressin for nocturnal enuresis. Cochrane Database Syst Rev; CD002112

  9. Glazener CM, Evans JH (2007) Alarm interventions for nocturnal enuresis in children (Cochrane Review). The Cochrane Library. Update Software, Oxford

  10. Hägglöf B, Andrén O, Bergström E et al (1997) Selfesteem before and after treatment in children with nocturnal enuresis and urinary incontinence. Scand J Urol Nephrol Suppl 183:79–82

    PubMed  Google Scholar 

  11. Harvey M, Baker K, Wells GA (2001) Tolterodine versus oxybutinin in the treatment of urge incontinence: a meta-analysis. Am J Obstet Gynecol 185:56–61

    Article  CAS  PubMed  Google Scholar 

  12. Hoebeke P, Bower W, Combs A et al (2010) Diagnostic evaluation of children with daytime incontinence. J Urol 183:699–703

    Article  CAS  PubMed  Google Scholar 

  13. Kamperis K, Hagstroem S, Rittig S et al (2008) Combination of the enuresis alarm and desmopressin. Second line treatment for enuresis nocturna. J Urol 179:1128–1131

    Article  PubMed  Google Scholar 

  14. Koşar A, Arikan N, Dinçel C (1999) Effectiveness of oxybutinin hydrochloride in the treatment of enuresis nocturna. Scand J Urol Nephrol 33:115–118

    Article  PubMed  Google Scholar 

  15. Kruse S, Hellström AL, Hjälmås K (1999) Daytime bladder dysfunction in therapy-resistant nocturnal enuresis. A pilot study in urotherapy. Scand J Urol Nephrol 33:49–52

    Article  CAS  PubMed  Google Scholar 

  16. Nevéus T, Läckgren G, Tuvemo T et al (1999) Desmopressin-resistant enuresis: pathogenetic and therapeutic considerations. J Urol 162:2136–2140

    Article  PubMed  Google Scholar 

  17. Nevéus T, Gontard A von, Hoebeke P et al (2006) The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardization Committee of the International Children‘s Continence Society (ICCS). J Urol 176:314–324

    Article  PubMed  Google Scholar 

  18. Nevéus T, Eggert P, Evans J et al (2010) Evaluation of and treatment for monosymptomatic enuresis: A standardization document from the I International Children‘s Continence Society (ICCS). J Urol 183:441–447

    Article  PubMed  Google Scholar 

  19. Riccabona M, Oswald J, Glauninger P (1998) Long-term use and tapered dose reduction of intranasal desmopressin in the treatment of enuretic children. Br J Urol 81(Suppl 3):24–25

    CAS  PubMed  Google Scholar 

  20. Rittig S, Knudsen UB, NØrgaard JP et al (1989) Abnormal diurnal thythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 256:F664–671

    CAS  PubMed  Google Scholar 

  21. Serel TA, Perk H, Koyuncuoglu HR et al (2001) Acupuncture therapy in the management of persistent primary nocturnal enuresis – preliminary results. Scand J Urol Nephrol 35:40–43

    Article  CAS  PubMed  Google Scholar 

  22. Gontard A von, Mauer-Mucke K, Pluck J et al (1999) Clinical behavioral problems in day- and night-wetting children. Pediatr Nephrol 13:662–667

    Article  Google Scholar 

  23. Wolfish NM, Pivik RT, Busby KA (1997) Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatr 86:381–384

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Riccabona.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riccabona, M. Evaluierung und Management der Enuresis. Urologe 49, 861–870 (2010). https://doi.org/10.1007/s00120-010-2328-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-010-2328-2

Schlüsselwörter

Keywords

Navigation